Laquisha Quinchele Lloyd, LPN | |
2247 Peter Dr, Indianapolis, IN 46229-1979 | |
(317) 540-0838 | |
Not Available |
Full Name | Laquisha Quinchele Lloyd |
---|---|
Gender | Female |
Speciality | Non-emergency Medical Transport (van) |
Location | 2247 Peter Dr, Indianapolis, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174091631 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Laquisha Quinchele Lloyd, LPN 2247 Peter Dr, Indianapolis, IN 46229-1979 Ph: (317) 540-0838 | Laquisha Quinchele Lloyd, LPN 2247 Peter Dr, Indianapolis, IN 46229-1979 Ph: (317) 540-0838 |
News Archive
Tranzyme Pharma announced today that data from the Phase 2 clinical trial of ulimorelin (TZP-101) for the treatment of severe gastroparesis have been selected for an oral presentation at Digestive Disease Week (DDW) 2010 being held May 1-5, 2010 in New Orleans, LA.
Scientists at the research Institute MIRA at the University of Twente have been working for some time on a new technique to detect breast cancer. The technique based on the physical principle of photoacoustics, has been christened PAMmography. It uses short bursts of light that cause ultrasonic waves to be generated in places with high density of blood vessels, such as in the vicinity of malignant tumours.
People who are exposed to paint, glue or degreaser fumes at work may experience memory and thinking problems in retirement, decades after their exposure, according to a study published in the May 13, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.
River blindness is a disease transmitted by biting flies, affecting areas such as West Africa, Nigeria, Congo, the Central African Republic and Central and South America, and causing significant health problems for at least 18 million people.
› Verified 3 days ago